How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Description:
This study is being done to learn how 18F-FSPG PET/CT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer.
Sponsor:
MD Anderson Cancer Center
Government Study Link:
NCT06549413 - Click here to see study onClinicalTrials.gov
18F-FSPG
Isotope(s):
Target(s):
- Cystine/glutamate antiporter
